Epithelial exosomes and TLR-mediated mucosal defense

上皮外泌体和 TLR 介导的粘膜防御

基本信息

  • 批准号:
    8496696
  • 负责人:
  • 金额:
    $ 28.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epithelial cells along the mucosal surface provide the front line of host defense against pathogen infection in the gastrointestinal (Gl) tract. Because of the importance of Toll-like receptor (TLR) signaling in the initiation and regulation of Gl mucosal immunity, the overall objective of this application is to better understand the molecular mechanisms by which TLR signaling coordinates Gl epithelial antimicrobial defense. Our preliminary studies demonstrate that microbial challenge stimulates exosome release from the apical side of cultured Gl epithelial monolayers in a TLR4-dependent manner. Released exosomes shuttle a variety of antimicrobial peptides and display antimicrobial activity ex vivo. Moreover, activation of TLR4/NF-?B signaling causes alterations in expression of microRNAs (miRNAs), small non-coding miRNAs that regulate gene expression at the posttranscriptional level. Selected TLR4-responsive miRNAs may target effector molecules that regulate the exocytotic process and, thus, are potentially involved in TLR4-mediated exosome release. Based on these exciting novel preliminary data, we propose to test the hypothesis that the release of exosomes from epithelial cells is regulated by TLR signaling with the involvement of miRNA- mediated gene regulation at the posttranscriptional level, and that it contributes to TLR-mediated Gl epithelial antimicrobial defense. We will use in vitro and in vivo infection models and complementary biochemical, molecular, and morphologic approaches to test four interrelated Specific Aims: i) The TLR signaling pathway regulates release of apical exosomes from epithelial cells in response to microbial challenge; ii) TLR signaling stimulates exosome release from epithelial cells through the IKK/SNAP-23- associated exocytotic process with the involvement of miRNA-mediated posttranscriptional regulation; iii) TLR signaling regulates exosomal shuttling of antimicrobial peptides; and iv) epithelial exosomes contribute to TLR-mediated epithelial antimicrobial defense. The proposal is conceptually innovative as it tests new concepts regarding TLR-mediated mucosal antimicrobial defense. The information obtained from this study should provide a rational basis for the design and implementation of new therapeutic strategies.
描述(由申请人提供):粘膜表面的上皮细胞为宿主抵御胃肠道(Gl)病原体感染提供了第一线的防御。由于Toll样受体(Toll-like Receptor,TLR)信号在Gl黏膜免疫的启动和调节中的重要性,本研究的总体目的是为了更好地了解TLR信号协调Gl上皮抗菌防御的分子机制。我们的初步研究表明,微生物刺激以TLR4依赖的方式刺激培养的Gl上皮单层顶端的外切体释放。释放的外切体穿梭于多种抗菌肽之间,并在体外显示出抗菌活性。此外,TLR4/NF-?B信号的激活会导致microRNAs(MiRNAs)的表达发生变化,miRNAs是一种在转录后水平调节基因表达的非编码的小miRNAs。选定的TLR4应答miRNAs可能以调控胞吐过程的效应分子为靶标,因此,可能参与TLR4介导的外体释放。基于这些令人兴奋的新的初步数据,我们建议检验这样一种假设,即上皮细胞外切体的释放受到TLR信号的调控,参与了miRNA介导的转录后水平的基因调控,并有助于TLR介导的Gl上皮细胞的抗菌防御。我们将使用体外和体内感染模型以及互补的生化、分子和形态学方法来测试四个相互关联的特定目标:i)TLR信号通路调节顶端外切体的释放以响应微生物的挑战;ii)TLR信号通过与IKK/SNAP-23相关的胞吐过程刺激上皮细胞释放外切体,参与miRNA介导的转录后调控;iii)TLR信号调节抗菌肽的外切体穿梭;以及iv)上皮外切体参与TLR介导的上皮抗菌防御。该提案在概念上是创新的,因为它测试了关于TLR介导的粘膜抗菌防御的新概念。从这项研究中获得的信息应该为设计和实施新的治疗策略提供合理的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xian-Ming Chen其他文献

Xian-Ming Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xian-Ming Chen', 18)}}的其他基金

Intestinal Stem Cell Responses to Cryptosporidium Infection
肠道干细胞对隐孢子虫感染的反应
  • 批准号:
    10330758
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
LncRNA regulation of Type I IFN signaling in intestinal epithelium
LncRNA 对肠上皮 I 型 IFN 信号传导的调节
  • 批准号:
    10321685
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
LncRNA regulation of Type I IFN signaling in intestinal epithelium
LncRNA 对肠上皮 I 型 IFN 信号传导的调节
  • 批准号:
    10331247
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
LincRNAs in Mucosal Defense to AIDS Opportunistic Pathogen Cryptosporidium
LincRNA 在粘膜防御艾滋病机会性病原体隐孢子虫中的作用
  • 批准号:
    10327943
  • 财政年份:
    2017
  • 资助金额:
    $ 28.88万
  • 项目类别:
LincRNAs in Mucosal Defense to AIDS Opportunistic Pathogen Cryptosporidium
LincRNA 在粘膜防御艾滋病机会病原体隐孢子虫中的作用
  • 批准号:
    10289715
  • 财政年份:
    2017
  • 资助金额:
    $ 28.88万
  • 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
  • 批准号:
    10359132
  • 财政年份:
    2015
  • 资助金额:
    $ 28.88万
  • 项目类别:
Molecular Basis of Intestinal Cryptosporidiosis
肠道隐孢子虫病的分子基础
  • 批准号:
    8920363
  • 财政年份:
    2015
  • 资助金额:
    $ 28.88万
  • 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
  • 批准号:
    10324243
  • 财政年份:
    2015
  • 资助金额:
    $ 28.88万
  • 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
  • 批准号:
    10019152
  • 财政年份:
    2015
  • 资助金额:
    $ 28.88万
  • 项目类别:
Molecular Basis of Intestinal Cryptosporidiosis
肠道隐孢子虫病的分子基础
  • 批准号:
    9419285
  • 财政年份:
    2015
  • 资助金额:
    $ 28.88万
  • 项目类别:

相似海外基金

Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
  • 批准号:
    EP/Y031067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307222
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
  • 批准号:
    502587
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307223
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
  • 批准号:
    MR/X009580/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
  • 批准号:
    2340818
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
  • 批准号:
    BB/X010473/1
  • 财政年份:
    2023
  • 资助金额:
    $ 28.88万
  • 项目类别:
    Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
  • 批准号:
    10670613
  • 财政年份:
    2023
  • 资助金额:
    $ 28.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了